An AAFCO feeding trial is one of the recognized ways a pet food can support a complete-and-balanced claim for a specific life stage. In practical terms, the food is fed to animals under a defined protocol and must meet minimum outcome criteria. That makes feeding trials important, but it does not make them the only meaningful form of substantiation. A product can be nutritionally sound without having completed a feeding trial, and a feeding-trial claim does not automatically prove long-term superiority. The real value lies in understanding what was tested, for which species and life stage, and how the claim is presented on the label.
If you want to know whether a food used an AAFCO feeding trial, the most useful place to look is the nutritional adequacy statement, sometimes called the statement of nutritional sufficiency. This is the small section of label text that explains whether the product is complete and balanced and how that claim is supported.
It is also important to separate AAFCO’s role from regulatory approval. AAFCO develops model rules, definitions and nutritional frameworks used widely in the United States, but it does not approve, certify or endorse individual pet foods. A feeding-trial statement therefore means the manufacturer is using a specific substantiation pathway under AAFCO-aligned rules. It does not mean AAFCO has tested the product itself.
Under AAFCO model rules, often referenced through the nutritional adequacy provisions in PF7, there are three main routes used to support a complete-and-balanced claim.
| Substantiation route | Typical label wording | What it tells you | Main limitation |
|---|---|---|---|
| Formulated to meet nutrient profiles | Formulated to meet AAFCO nutrient levels for a life stage | The recipe is designed to meet the relevant nutrient profile on paper, supported by formulation and analytical data | It does not by itself show how the finished product performs when fed |
| Animal feeding tests | Animal feeding tests using AAFCO procedures substantiate the claim | The finished food has been fed in a defined study and met the protocol criteria | The study is limited in duration, population size and endpoints |
| Family product or comparable product route | Supported through a lead product in the same family | A related product has passed the required substantiation and the new product fits the allowed comparison rules | The marketed product may not have been directly trialed itself |
For many buyers, this table explains why the words complete and balanced do not all mean exactly the same thing. It also explains why treats, toppers and other complementary products often do not carry a complete-and-balanced statement at all. Their intended use is different.
The best-known example is the adult maintenance feeding trial for dogs or cats. While exact requirements should always be checked in the latest AAFCO Official Publication and any applicable state rules, the traditional structure has been fairly consistent: a small group of healthy adult animals is fed the test diet for a set period, historically around 26 weeks for adult maintenance. The animals are observed throughout the study, and the outcome is judged against predefined criteria.
In general, these studies look at practical markers such as survival, overall clinical condition, body weight stability and selected blood parameters. A limited number of removals may be allowed, but enough animals must complete the study for the product to pass. The logic is straightforward: the food must do more than look good on paper. It must sustain a defined group of animals through the test period without failing the protocol.
Life-stage claims raise a higher level of sensitivity. Growth diets, including products aimed at puppies or kittens, and foods for gestation or lactation involve more demanding nutritional needs than adult maintenance. That is why discussions around feeding-trial updates often focus on whether current protocols are specific enough, especially where large-breed puppy growth and nutrient limits such as calcium are concerned.
For manufacturers, this matters because a protocol change can affect far more than a labelling sentence. It can influence formulation targets, required study design, launch timing and whether a claim is appropriate for a particular subgroup. When AAFCO reviews these protocols, the impact can run across R&D, regulatory, sourcing and commercial planning at the same time.
Feeding trials have real value. They test the finished product rather than only a nutrient calculation, and they can reveal practical issues such as poor acceptance, instability or performance gaps that are not obvious from formulation software alone. For novel ingredients, significant recipe changes or higher-risk product concepts, that kind of evidence can be very useful.
At the same time, the limitations are just as important.
This is why the industry debate around formulated claims versus feeding-trial claims continues. Some professionals see feeding trials as the stronger signal because they involve the finished diet in real animals. Others point out that modern nutrition knowledge, ingredient control, digestibility work, quality systems and expert formulation can make a well-designed formulated product entirely credible. The more balanced view is that each route answers a different question. A feeding trial is not meaningless, but it is also not a universal gold standard for every product decision.
Animal welfare is part of that discussion as well. Because feeding trials involve live animals, many companies now think more carefully about when a study is truly necessary and how the principles of reduction, refinement and replacement can be applied. In practice, that means using trials where they add clear technical value rather than treating them as a default marketing tool.
Choosing a substantiation pathway is not just a regulatory checkbox. It shapes formulation work, claim wording, test planning, packaging timelines and market-entry risk. A company that waits until artwork is nearly complete to decide between nutrient-profile substantiation, a family-product route or a feeding study can create expensive rework.
This becomes even more important for companies active across regions. AAFCO-based U.S. claims and FEDIAF-based European nutritional guidance are not interchangeable, even when the product concept looks similar. If you are developing a food for multiple markets, the substantiation strategy should be aligned early with technical, regulatory and commercial goals. That is often where a practical, end-to-end consulting approach saves time and reduces launch risk.
No. AAFCO does not approve, test or certify individual pet foods. It publishes model standards and definitions that are widely used by regulators and industry. A label statement referring to AAFCO procedures means the product is using an AAFCO-recognized substantiation route, not that AAFCO has endorsed the food.
No. A feeding-trial claim shows that the finished product passed a defined study, which is meaningful, but it does not automatically make the product better than every food formulated to meet nutrient profiles. Product quality depends on the full picture: formulation expertise, ingredient quality, manufacturing control, stability, digestibility and whether the diet suits the intended animal.
There is no single official AAFCO public list that reliably tells you every dog or cat food that used feeding trials. The most dependable source is the nutritional adequacy statement on the specific product label. If the wording says animal feeding tests using AAFCO procedures substantiate the claim, that product is using the feeding-trial route for the stated life stage.
Yes. Dogs and cats have different nutritional requirements, and the applicable protocols differ by species and life stage. Adult maintenance, growth and reproduction are not interchangeable claims. When reviewing a product, always check that the statement matches the intended species and the exact life stage being marketed.
Usually not, unless they are specifically intended to serve as the sole ration and have been substantiated accordingly. Many treats, toppers and complementary products are designed for intermittent or supplemental feeding, so they use different label statements. That distinction matters when assessing whether a product is a full diet or only part of one.
If you are evaluating feeding-trial strategy, label wording or cross-market substantiation for a pet food project, GC Consulting supports brands and manufacturers with practical technical, regulatory and commercial guidance from product concept through market launch.